<H1>Chapter DOI: 10.1208/aapsj070489<br/>Cited-By Count: 27</H1><table border="1" width="30%"><tr><td>Total References</td><td>50</td></tr><tr><td>Springer references</td><td>1</td></tr><tr><td>Non Springer references</td><td>49</td></tr><tr><td>BibStructured Count</td><td width="10%">50</td></tr><tr><td>BibUnstructured Count</td><td width="10%">0</td></tr><tr><td>DOI already available in SpringerLink</td><td>39</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>3</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>4</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Uetrecht JP. New concepts in immunology relevant to idiosyncratic drug reactions: the &#8220;danger hypothesis&#8221; and innate immune system.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 1999;12:387&#8211;395</td><td><a href=http://dx.doi.org/10.1021/tx980249i>10.1021/tx980249i</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Knowles SR, Uetrecht JP, Shear NH. Confirming false adverse reactions to drugs by performing individualized, randomized trials.<Emphasis Type="Italic">Can J Clin Pharmacol.</Emphasis> 2002;9:149&#8211;153.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Macy E. Multiple antibiotic allegry syndrome.<Emphasis Type="Italic">Immunol Allergy Clin North Am.</Emphasis> 2004;24:533&#8211;543.</td><td><a href=http://dx.doi.org/10.1016/j.iac.2004.03.002>10.1016/j.iac.2004.03.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Jaffe IA. Induction of auto-immune syndromes by penicillamine therapy in rheumatoid arthritis and other diseases.<Emphasis Type="Italic">Springer Semin Immunopathol.</Emphasis> 1981;4:193&#8211;207.</td><td><a href=http://dx.doi.org/10.1007/BF01857095>10.1007/BF01857095</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Weiss AS, Markenson JA, Weiss MS, Kammerer WH. Toxicity of D-penicillamine in rheumatoid arthritis: a report of 63 patients including 2 with aplastic anemia and one with the nephrotic syndrome.<Emphasis Type="Italic">Am J Med.</Emphasis> 1978;64:114&#8211;120.</td><td><a href=http://dx.doi.org/10.1016/0002-9343(78)90186-9>10.1016/0002-9343(78)90186-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Stein HB, Patterson AC, Offer RC, Atkins CJ, Teufel A, Robinson HS. Adverse effects of D-penicillamine in rheumatoid arthritis.<Emphasis Type="Italic">Ann Intern Med.</Emphasis> 1980;92:24&#8211;29.</td><td><a href=http://dx.doi.org/10.7326/0003-4819-92-1-24>10.7326/0003-4819-92-1-24</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, Year, Author_FamilyName_1, VolumeID</td><td>CrossRef</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Donker AJ, Venuto RC, Vladutiu AO, Brentjens JR, Andres GA. Effects of prolonged administration of D-penicillamine or captopril in various strains of rats.<Emphasis Type="Italic">Clin Immunol Immunopathol.</Emphasis> 1984;30:142&#8211;155.</td><td><a href=http://dx.doi.org/10.1016/0090-1229(84)90015-1>10.1016/0090-1229(84)90015-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Tournade H, Pelletier L, Pasquier R, Vial M, Mandet C, Druet P. D-Penicillamine-induced autoimmunity in Brown-Norway rats: similarities with HgCl<Subscript>2</Subscript>-induced autoimmunity.<Emphasis Type="Italic">J Immunol.</Emphasis> 1990;144:2985&#8211;2991.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Masson MJ, Uetrecht JP. Tolerance induced by low dose D-penicillamine in the Brown Norway rat model of drug-induced autoimmunity is immune-mediated.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2004;17:82&#8211;94.</td><td><a href=http://dx.doi.org/10.1021/tx034195a>10.1021/tx034195a</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Seguin B, Masson MJ, Uetrecht J. D-penicillamine-induced autoimmunity in the Brown Norway rat: role for both T and non-T splenocytes in adoptive transfer of tolerance.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2004;17:1299&#8211;1302.</td><td><a href=http://dx.doi.org/10.1021/tx0498399>10.1021/tx0498399</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Sayeh E, Uetrecht JP. Factors that modify penicillamine-induced autoimmunity in Brown Norway rats: failure of the Th1/Th2 paradigm.<Emphasis Type="Italic">Toxicology</Emphasis>, 2001;163:195&#8211;211.</td><td><a href=http://dx.doi.org/10.1016/S0300-483X(01)00385-7>10.1016/S0300-483X(01)00385-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Seguin B, Boutros PC, Li X, Okey AB, Uetrecht JP. Gene expression profiling in a model of d-penicillamine-induced autoimmunity in the Brown Norway rat: predictive value of early signs of danger.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2005;18:1193&#8211;1202.</td><td><a href=http://dx.doi.org/10.1021/tx050040m>10.1021/tx050040m</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Masson MJ, Teranishi M, Shenton JM, Uetrecht JP. Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat.<Emphasis Type="Italic">J Immunotoxicol.</Emphasis> 2004;1:79&#8211;93.</td><td><a href=http://dx.doi.org/10.1080/15476910490496258>10.1080/15476910490496258</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Rhodes J. Evidence for an intercellular covalent reaction essential in antigen-specific T cell activation.<Emphasis Type="Italic">J Immunol.</Emphasis> 1989;143:1482&#8211;1489.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Uetrecht J. Current trends in drug-induced autoimmunity.<Emphasis Type="Italic">Autoimmun Rev.</Emphasis> 2005:4:309&#8211;314.</td><td><a href=http://dx.doi.org/10.1016/j.autrev.2005.01.002>10.1016/j.autrev.2005.01.002</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Bersoff-Matcha SJ, Miller WC, Aberg JA, et al. Sex differences in nevirapine rash.<Emphasis Type="Italic">Clin Infect Dis.</Emphasis> 2001;32:124&#8211;129.</td><td><a href=http://dx.doi.org/10.1086/317536>10.1086/317536</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Shenton JM, Teranishi M, Abu-Asab MS, Yager JA, Uetrecht JP. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2003;16:1078&#8211;1089.</td><td><a href=http://dx.doi.org/10.1021/tx034064+>10.1021/tx034064+</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Shenton JM, Popovic M, Chen J, Masson MJ, Uetrecht JP. Evidence of an immune-mediated mechanism for an idiosyncratic nevirapine-induced reaction in the female brown norway rat<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2005;18:1799&#8211;1813.</td><td><a href=http://dx.doi.org/10.1021/tx0501132>10.1021/tx0501132</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Aucoin DP, Peterson ME, Hurvitz AI, et al. Propylthiouracil-induced immune-mediated disease in the cat.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1985;234:13&#8211;18.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Aucoin DP, Rubin RL, Peterson ME, et al. Dose-dependent induction of antinative DNA antibodies in cats by propylthiouracil.<Emphasis Type="Italic">Arthritis Rheum.</Emphasis> 1988;31:688&#8211;692.</td><td><a href=http://dx.doi.org/10.1002/art.1780310517>10.1002/art.1780310517</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Waldhauser L, Uetrecht J. Antibodies to myeloperoxidase in propylthiouracil-induced autoimmune disease in the cat.<Emphasis Type="Italic">Toxicology</Emphasis>. 1996;114:155&#8211;162.</td><td><a href=http://dx.doi.org/10.1016/S0300-483X(96)03476-2>10.1016/S0300-483X(96)03476-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Waldhauser L, Uetrecht J. Oxidation of propylthiouracil to reactive metabolites by activated neutrophils: implications for agranulocytosis.<Emphasis Type="Italic">Drug Metab Dispos.</Emphasis> 1991;19:354&#8211;359.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Elkayam O, Yaron M, Caspi D. Minocycline-induced autoimmune syndromes: an overview.<Emphasis Type="Italic">Semin Arthritis Rheum.</Emphasis> 1999;28:392&#8211;397.</td><td><a href=http://dx.doi.org/10.1016/S0049-0172(99)80004-3>10.1016/S0049-0172(99)80004-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>N&#228;ssberger L, Sj&#246;holm AG, Jonsson H, Sturfelt G, &#197;kesson A. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus.<Emphasis Type="Italic">Clin Exp Immunol.</Emphasis> 1990;81:380&#8211;383.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2249.1990.tb05342.x>10.1111/j.1365-2249.1990.tb05342.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Trepanier LA. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog.<Emphasis Type="Italic">J Vet Pharmacol Ther.</Emphasis> 2004;27:129&#8211;138.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2885.2004.00576.x>10.1111/j.1365-2885.2004.00576.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibBook</td><td>Zimmerman H.<Emphasis Type="Italic">Hepatotoxicity: The Adverse Effects of Drugs and Other Chemicals on the Liver</Emphasis>; Philadelphia, PA: Lippincott Williams &amp; Wilkins. 1999.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/s0016-5085(00)70192-2>10.1016/s0016-5085(00)70192-2</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Kenna JG, Neuberger J, Williams R. Identification by immunoblotting of 3 halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1987;242:733&#8211;740.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Satoh H, Martin BM, Schulick AH, Christ DD, Kenna JG, Pohl LR. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a trifluoroacetylated carboxylesterase.<Emphasis Type="Italic">Proc Natl Acad Sci USA.</Emphasis> 1989;86:322&#8211;326.</td><td><a href=http://dx.doi.org/10.1073/pnas.86.1.322>10.1073/pnas.86.1.322</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Bourdi M, Chen W, Peter RM, et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 1996;9:1159&#8211;1166.</td><td><a href=http://dx.doi.org/10.1021/tx960083q>10.1021/tx960083q</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>McLain GE, Sipes IG, Brown BR. An animal model of halothane hepatotoxicity: roles of enzyme induction and hypoxia.<Emphasis Type="Italic">Anesthesiology</Emphasis> 1979;51:321&#8211;326.</td><td><a href=http://dx.doi.org/10.1097/00000542-197910000-00008>10.1097/00000542-197910000-00008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Furst SM, Luedke D, Gaw HH, Reich R, Gandolfi AJ. Demonstration of a cellular immune response in halothane-exposed guinea pigs.<Emphasis Type="Italic">Toxicol Appl Pharmacol.</Emphasis> 1997;143:245&#8211;255.</td><td><a href=http://dx.doi.org/10.1006/taap.1996.8093>10.1006/taap.1996.8093</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Maggs JL, Tingle MD, Kitteringham NR, Park BK. Drug-protein conjugates-XIV: mechanisms of formation of protein-arylating intermediates from amodiaquine, a myelotoxin, and hepatoxin in man.<Emphasis Type="Italic">Biochem Pharmacol.</Emphasis> 1988;37:303&#8211;311.</td><td><a href=http://dx.doi.org/10.1016/0006-2952(88)90733-2>10.1016/0006-2952(88)90733-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Clarke JB, Neftel K, Kitteringham NR, Park BK. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine.<Emphasis Type="Italic">IntArch Allergy Appl Immunol.</Emphasis> 1991;95:369&#8211;375.</td><td><a href=http://dx.doi.org/10.1159/000235475>10.1159/000235475</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, FirstPage, Author_FamilyName_2, ArticleTitle, VolumeID</td><td>CrossRef</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Clarke JB, Maggs JL, Kitteringham NR, Park BK. Immunogenicity of amodiaquine in the rat.<Emphasis Type="Italic">Int Arch Allergy Appl Immunol.</Emphasis> 1990;91:335&#8211;342.</td><td><a href=http://dx.doi.org/10.1159/000235138>10.1159/000235138</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, Year, ArticleTitle, Author_FamilyName_2, VolumeID</td><td>CrossRef</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Timbrell JA, Mitchell JR, Snodgrass WR, Nelson SD. Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1980;213:364&#8211;369.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Sarich TC, Zhou T, Adams SP, Bain AI, Wall RA, Wright JM. A model of isoniazid-induced hepatotoxicity in rabbits.<Emphasis Type="Italic">J Pharmacol Toxicol Methods.</Emphasis> 1995;34:109&#8211;116.</td><td><a href=http://dx.doi.org/10.1016/1056-8719(95)00044-I>10.1016/1056-8719(95)00044-I</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Luyendyk JP, Maddox JF, Cosma GN, Ganey PE, Cockerell GL, Roth RA. Ranitidine treatment during a modest inflammatory response precipitates idioxyncrasy-like liver injury in rats.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;307:9&#8211;16.</td><td><a href=http://dx.doi.org/10.1124/jpet.103.054288>10.1124/jpet.103.054288</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Luyendyk JP, Shaw PJ, Green CD, Maddox JF, Ganey PE, Roth RA. Coagulation-mediated hypoxia and neutrophil-dependent hepatic injury in rats given lipopolysaccharide and ranitidine.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2005:314:1023&#8211;1031.</td><td><a href=http://dx.doi.org/10.1124/jpet.105.087981>10.1124/jpet.105.087981</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Roth RA, Luyendyk JP, Maddox JF, Ganey PE. Inflammation and drug idiosyncrasy: is there a connection?,<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2003;307:1&#8211;8.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.041624>10.1124/jpet.102.041624</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Pieters R, Ezendam J, Bleumink R, Bol M, Nierkens S. Predictive testing for autoimmunity.<Emphasis Type="Italic">Toxicol Lett.</Emphasis> 2002;127:83&#8211;91.</td><td><a href=http://dx.doi.org/10.1016/S0378-4274(01)00487-8>10.1016/S0378-4274(01)00487-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Evans DC, Watt AP, Nicoll-Griffith DA, Baillie TA. Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.<Emphasis Type="Italic">Chem Res Toxicol.</Emphasis> 2004;17:3&#8211;16.</td><td><a href=http://dx.doi.org/10.1021/tx034170b>10.1021/tx034170b</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Bloksma N, Kubicka-Muranyi M, Schuppe H, Gleichmann E, Gleichmann H. Predictive immunotoxicological test systems: suitability of the popliteal lymph node assay in mice and rats.<Emphasis Type="Italic">Crit Rev Toxicol.</Emphasis> 1995;25:369&#8211;396.</td><td><a href=http://dx.doi.org/10.3109/10408449509049338>10.3109/10408449509049338</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Gutting BW, Schomaker SJ, Kaplan AH, Amache DE. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds.<Emphasis Type="Italic">Toxicol Sci.</Emphasis> 1999;51:71&#8211;79.</td><td><a href=http://dx.doi.org/10.1093/toxsci/51.1.71>10.1093/toxsci/51.1.71</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Nierkens S, Nieuwenhuijsen L, Thomas M, Pieters R. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.<Emphasis Type="Italic">Toxicol Sci.</Emphasis> 2004:79:90&#8211;97.</td><td><a href=http://dx.doi.org/10.1093/toxsci/kfh074>10.1093/toxsci/kfh074</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, Svensson CK, Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2005;314:43&#8211;52.</td><td><a href=http://dx.doi.org/10.1124/jpet.105.086009>10.1124/jpet.105.086009</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Kammueller ME, Seinen W. Structural requirements for hydantoins and 2-thiohydantoins to induce lymphoproliferative popliteal lymph node reactions in the mouse.<Emphasis Type="Italic">Int J Immunopharmacol.</Emphasis> 1988;10:997&#8211;1010.</td><td><a href=http://dx.doi.org/10.1016/0192-0561(88)90047-1>10.1016/0192-0561(88)90047-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.<Emphasis Type="Italic">Nat Rev Immunol.</Emphasis> 2004;4:469&#8211;478.</td><td><a href=http://dx.doi.org/10.1038/nri1372>10.1038/nri1372</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Wooley PH, Whalen JD. Pristane-induced arthritis in mice. III. Lymphocyte phenotypic and functional abnormalities precede the development of pristane-induced arthritis.<Emphasis Type="Italic">Cell Immunol.</Emphasis> 1991;138:251&#8211;259.</td><td><a href=http://dx.doi.org/10.1016/0008-8749(91)90150-A>10.1016/0008-8749(91)90150-A</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Albers R, Broeders A, van der Pijl A, Seinen W, Pieters R. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals.<Emphasis Type="Italic">Toxicol Appl Pharmacol.</Emphasis> 1997;143:102&#8211;109.</td><td><a href=http://dx.doi.org/10.1006/taap.1996.8078>10.1006/taap.1996.8078</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Nierkens S, Aalbers M, Bol M, van Wijk F, Hassing I, Pieters R. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens.<Emphasis Type="Italic">Toxicol Sci.</Emphasis> 2005;83:273&#8211;281.</td><td><a href=http://dx.doi.org/10.1093/toxsci/kfi021>10.1093/toxsci/kfi021</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>